Letermovir for prophylaxis of cytomegalovirus (CMV) infection or disease in allogeneic hct recipients: Experience of secondary prophylaxis in the French compassionate program

被引：0
|
作者：
Robin, Christine [1 ,2 ]
Ducastelle-Lepretre, Sophie [3 ]
Thiebaut, Anne [4 ]
de la Tour, Regis Peffault [5 ]
Ceballos, Patrice [6 ]
Masure, Marion [7 ]
Allavoine, Thierry [8 ]
Benard, Nathalie [9 ]
Rubio, Marie Therese [10 ]
Yacoub-Agha, Ibrahim
Guidoum, Amir [9 ]
Alain, Sophie [11 ]
Cordonnier, Catherine [1 ,2 ]
机构：
[1] Henri Mondor Hosp, APHP, Creteil, France
[2] UPEC, Hematol, Creteil, France
[3] Hosp Civils Lyon, Hematol, Lyon, France
[4] Ctr Hosp Univ Grenoble, Hematol, Grenoble, France
[5] St Louis Hosp, APHP, Paris, France
[6] Hop St Eloi, Hematol, Montpellier, France
[7] ICTA PM, Fontaine Les Dijon, France
[8] MSD France, Lyon, France
[9] MSD France, Courbevoie, France
[10] CHRU Nancy Brabois, Hematol, Vandoeuvre Les Nancy, France
[11] CHU Dupuytren, Ctr Natl Reference CMV, Limoges, France
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P406
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [1] Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program
    Robin, Christine
    Thiebaut, Anne
    Alain, Sophie
    de Fontbrune, Flore Sicre
    Berceanu, Ana
    D'Aveni, Maud
    Ceballos, Patrice
    Redjoul, Rabah
    Nguyen-Quoc, Stephanie
    Benard, Nathalie
    Pahlavan-Grumel, Golriz
    Cordonnier, Catherine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : 978 - 984
  • [2] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [3] Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program
    Beauvais, David
    Robin, Christine
    Thiebaut, Anne
    Alain, Sophie
    Coiteux, Valerie
    Ducastelle-Lepretre, Sophie
    Marcais, Ambroise
    Ceballos, Patrice
    Xhaard, Alienor
    Redjoul, Rabah
    Nguyen, Stephaine
    Brissot, Eolia
    Joris, Magalie
    Turlure, Pascal
    Rubio, Marie-Therese
    Chevallier, Patrice
    Benard, Nathalie
    Liautard, Camille
    Yakoub-Agha, Ibrahim
    JOURNAL OF CLINICAL VIROLOGY, 2022, 148
  • [4] Letermovir for prophylaxis of cytomegalovirus in allogeneic hematopoietic stem cell recipients
    Cho, J. C.
    Le, A. D.
    Locke, S. C.
    DRUGS OF TODAY, 2018, 54 (06) : 361 - 368
  • [5] Use of Letermovir for Cytomegalovirus (CMV) Prophylaxis in Orthotopic Heart Transplant Recipients
    Golob, S.
    Uriel, M.
    Batra, J.
    Gaine, M.
    Clerkin, K.
    Raikhelkar, J.
    Fried, J.
    Griffin, J.
    Restaino, S.
    Lee, S.
    Majure, D.
    Yuzefpolskaya, M.
    Colombo, P.
    Latif, F.
    Pereira, M.
    Choe, J.
    Jennings, D.
    Sayer, G.
    Uriel, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S330 - S330
  • [6] Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience
    Desai, Nihar
    Pasic, Ivan
    Law, Arjun D.
    Lam, Wilson
    Gerbitz, Armin
    Viswabandya, Auro
    Kim, Dennis D.
    Kumar, Rajat
    Mattsson, Jonas
    Novitzky-Basso, Igor
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (04) : 477 - 484
  • [7] Breakthrough CMV Infections on Letermovir Prophylaxis in CMV-Seropositive Allogeneic Hematopoeitic Cell Transplant (allo-HCT) Recipients
    Shigle, Terri Lynn
    Handy, Victoria Wehr
    Foolad, Farnaz
    Khawaja, Fareed
    Aitken, Samuel L.
    Chemaly, Roy F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [8] CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
    Chavaz, Lara
    Royston, Lena
    Masouridi-Levrat, Stavroula
    Mamez, Anne-Claire
    Giannotti, Federica
    Morin, Sarah
    Van Delden, Christian
    Chalandon, Yves
    Neofytos, Dionysios
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (04):
  • [9] Real World Experience of Letermovir (LTV) Prophylaxis (Px) for the Prevention of Cytomegalovirus Infection (CMVi) in the Adult CMV Seropositive Recipients (R plus ) of Allogeneic Hematopoietic Cell Transplantation (HCT) Patients (pts)
    Dadwal, Sanjeet S.
    Al Malki, Monzr M.
    Yang, Dongyun
    Tegtmeier, Bernard R.
    Ross, Justine
    Mokhtari, Sally
    Marcucci, Guido
    Palmer, Joycelynne
    Salhotra, Amandeep
    Dickter, Jana
    O'Donnell, Margaret R.
    Smith, Eileen
    Karanes, Chatchada
    Snyder, David S.
    Mei, Matthew
    Pullarkat, Vinod
    Aldoss, Ibrahim
    Stein, Anthony S.
    Sandhu, Karamjeet S.
    Spielberger, Ricardo
    Nademanee, Auayporn
    Ito, James I.
    Forman, Stephen J.
    Zaia, John A.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [10] Risk factors associated with the development of clinically significant cytomegalovirus (CMV) infection in the allogeneic hematopoietic-cell transplant (HCT) letermovir prophylaxis trial
    Marty, Francisco M.
    Ellison, Misoo C.
    Rabitsch, Werner
    Itala-Remes, Maija
    Dominietto, Alida
    Peggs, Karl
    Browett, Peter
    Moreno, Mariela
    Leavitt, Randi Y.
    Joshi, Amita
    Badshah, Cyrus
    Yeh, Wendy W.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 101 - 102
12345